{
    "clinical_study": {
        "@rank": "80436", 
        "biospec_descr": {
            "textblock": "Plasma and Cerebrospinal fluid"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to elucidate the pharmacokinetics and the blood-brain barrier\n      penetration of the elemene."
        }, 
        "brief_title": "Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Cancer", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histopathological or cytopathology diagnosis of malignancy\n\n          -  heart, liver and renal function is normal\n\n          -  Expected survival time is more than 3 months\n\n          -  Signed informed consent\n\n        exclusion Criteria:\n\n          -  non cancer patient\n\n          -  accepted elemene administration in 1 month\n\n          -  Expected survival time is less than 3 months\n\n          -  no Signed informed consent\n\n          -  heart, liver and renal function is abnormal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "malignant patients"
            }
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679847", 
            "org_study_id": "HSZL201001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elemene", 
            "pharmacokinetics", 
            "Blood-brain barrier"
        ], 
        "lastchanged_date": "September 7, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200040"
                }, 
                "name": "Huashan Hospital of Fudan University"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "zjoan2121@gmail.com", 
            "last_name": "ZHAN QIONG, MD", 
            "phone": "8621-52887162"
        }, 
        "overall_official": {
            "affiliation": "Huashan Hospital of Fudan University", 
            "last_name": "liang xiaohua, phD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "blood and cerebrospinal fluid concentration", 
            "safety_issue": "No", 
            "time_frame": "0\uff0c0.25\uff0c0.5\uff0c1\uff0c1.5\uff0c2\uff0c3\uff0c3.5\uff0c4\uff0c6\uff0c8\uff0c12 hours post dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679847"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Dalian Holley Kingkong Pharmaceutical Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dalian Holley Kingkong Pharmaceutical Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Case-Only", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}